(Q45410448)

14 December 2017

title

Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour (English)

1 reference

14 December 2017

0 references

1 reference

Han Chong Toh

1

1 reference

14 December 2017

Marissa Teo

2

1 reference

14 December 2017

Kong Wee Ong

3

1 reference

14 December 2017

Victor Lee

4

1 reference

14 December 2017

Errol Chan

5

1 reference

14 December 2017

Ann S G Lee

6

1 reference

14 December 2017

Anantharaman Vathsala

7

1 reference

14 December 2017

publication date

1 November 2006

1 reference

Lancet Oncology Commission

14 December 2017

published in

1 reference

14 December 2017

volume

7

1 reference

14 December 2017

issue

11

1 reference

14 December 2017

page(s)

955-957

1 reference

Epstein-Barr virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation: case report and review of the literature

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

Epstein-Barr virus-associated pulmonary leiomyosarcoma arising twenty-nine years after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

Myocardial Epstein-Barr virus-associated cardiac smooth-muscle neoplasm arising in a cardiac transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

Epstein-Barr virus-associated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

Successful management of recurrent Epstein-Barr virus-associated multilocular leiomyosarcoma after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

A mammalian protein targeted by G1-arresting rapamycin-receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

mTOR-targeted therapy of cancer with rapamycin derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970943-3

7 January 2021

10.1016/S1470-2045(06)70943-3

Identifiers

DOI

1 reference

14 December 2017

1 reference